Calyxt, a plant-based synthetic biology company, has announced a manufacturing agreement with Evologic Technologies, under which the companies will develop and scale Calyxt’s Plant Cell Matrix technology platform. The agreement is intended to support the development of Calyxt’s synthetic biology capabilities and establish proof-of-concept for scaling up to commercial production of its Plant Cell Matrix platform.